Laws and Regulations

Total Page:16

File Type:pdf, Size:1020Kb

Laws and Regulations E/NL .1955/51-59 November 1955 UNITED NATIONS ORIGINAL: English LAWS AND REGULATIONS PROMULGATED TO GIVE EFFECT TO THE PROVISIONS OF THE CONVENTION OF 13 JULY 1931 FOR LIMITING THE MANUFACTURE AND REGULATING THE DISTRIBUTION OF NARCOTIC DRUGS, AS AMENDED BY THE PROTOCOL OF 11 DECEMBER 1946 AUSTRALIA Communicated by the Government of Australia NOTE BY THE SECRETARY-GENERAL ~ In accordance with Article 21 of the Convention of 13 July 1931 for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs, as amended by the Protocol of 11 December 1946, the Secretary- General has the honour to communicate the following legislative texts. E/NL. 1955/51 preparations, admixtures, extracts or other sub• stances containing any proportion of methadol or State of Victoria such derivatives. Morphinan and derivatives of morphinan such as Poisons Acts methorphinan, dextrorphan, laevorphan, levor- phan, racemorphan, dromoran, 3-methoxy-N- AMENDMENT OF THE SIXTH SCHEDULE TO THE methylmorphinan, dextromethorphan, laevome- POISONS ACT 1928 (No.3748) AS AMENDED BY thorphan, levomethorphan, racemethorphan; and ACT No. 3918. the salts, preparations, admixtures, extracts or other substances containing any proportion of PROCLAMATION morphinan or such derivatives. Morphine-N-oxide (also known as genomorphine) By His Excellency the Governor of the State of Victoria and all pentavalent nitrogen morphine deriva• and its Dependencies in the Commonwealth of tives; and the salts, preparations, admixtures, Australia, etc., etc., etc. extracts or other substances containing any proportion of morphine-N-oxide or such pen• tavalent nitrogen derivative. By virtue of the powers conferred by section thirty- Morphinone and derivatives of morphjnone such as eight of the Poisons Act 1928 (No. 3748) as amended dihydrohydroxycodeinone, mel!Rytatfi^2tromor- by section five of the Poisons Act 1930 (No. 3918), I, phinone,, gScycodone, ^hydrocodone, Jrydromor- the Governor of the State of Victoria by and with the phone; and the salts, preparations, admixtures, advice of the Executive Council of the said State and extracts or other substances containing any on the recommendation of the Pharmacy Board of proportion of morphinone or such derivatives. Victoria do by this my Proclamation add to paragraph Piperidine derivatives withhypnotic properties such (1) of the Sixth Schedule to the Poisons Act 1928 as as alphajSrodine, betapi'bdine, hydroxy pethidine,* amended by the Poisons Act 1930 the names of the bemidohe, ketobe^nidone, meprodine, alpliame- following substances or preparations, namely:- prodine, betameprodine; and the salts, prepara• tions, admixtures, extracts or other substances "Dihydrocodeine^and acyl derivatives of dihydroco- containing any proportion of such piperidine deine such asacetyldihydrocodeine, acetylgodone, derivatives. thebacon, bjjtyryWmydrocod^ine^ " parac5d"ine7" Thebaine, its salts and any preparation, admixture, paracodin; ana the s'aT£s,~ preparations, admix• extract or other substance containing any pro• tures^ extracts or other substances containing portion of thebaine." any proportion of dihydrocodeine or such deriva• tives. And declare that Division 2 of part III. of the Poisons Dihydromorphine, its salts and any preparation, Act 1928 as amended by the Poisons Act 1930 shall admixture, extract or other substance containing apply to the substances and preparations named herein any proportion of dihydromorphine. in the same manner as it applies to substances or Isomethadone (also known as isoamidone), its salts preparations mentioned in the said paragraph (1) of and any preparation, admixture, extract or other the Sixth Schedule and the provisions of the said substance containing any proportion of isometha• Division shall apply accordingly. done. Methadol and derivatives of methadol such as Given under my Hand and the Seal of the State of methadyl acetate, alpha-acetylmethadol, alpha- Victoria aforesaid, at Melbourne, this seventh methadol, beta-acetyl-methadol; and the salts, day of September, in the year of our Lord One thousand nine hundred and fifty-four, and in taining not less than one-fifth per centum of the third year of the reign of Her Majesty Queen Dihydrocodeine; Elizabeth II. Dihydrocodeinone, known as Hydrocodone, Dicodid, Hycodan, or other trade name, its salts, and any DALLAS BROOKS. preparation, admixture, extract or other sub• stance containing not less than one-fifth per By His Excellency's Command, centum of Dihydrocodeinone; Acetyldihydrocodeine, known as Acetylcodone, or WM. BARRY, other trade name, its salts, and any preparation, Minister of.Health. admixture, extract or other substance containing not less than one-fifth per centum of Acetyldi• GOD SAVE THE QUEEN'. hydrocodeine; Acetyldihydrocodeinone, known as Acedicone, No- vocodon, or other trade name, its salts, and any preparation, admixture, extract or other sub• stance containing not less than one-fifth per E/NL. 1955/52 centum of Acetyldihydrocodeinone; Dihydrohydroxycodeinone, known as Oxycodone, New South Wales. Eucodal, or other trade name, its salts, and any preparation, admixture, extract or other sub• POLICE OFFENCES (AMENDMENT) ACT, 1908, as stance containing not less than one-fifth per amended centum of Dihydrohydroxycodeinone; Benzimorphine, known as Peronine, or other trade PROCLAMATION. name, its salts, and any preparation, admixture, extract or other substance, containing not less f Published in Government Gazette No. 117 of 30th than one-fifth per centum of BenSlmorphine; July, 1954.1 Methylmorphine, known as Codeine or other trade name, its salts, and any preparation, admixture, (L.S.) J. NORTHCOTT, Governor. extract or other substance containing not less than one per centum of Methylmorphine. Ethylmorphine, known as Dionine, or other trade name, its salts, and any preparation, admixture, extract or other substance containing not less I, Sir John Northcott, Knight Commander of the Most than one per centum of Ethylmorphine; Distinguished Order of Saint Michael and Saint George, B-4-Morpholinylethylmorphine, known as Pholco- Knight Commander of the Royal Victorian Order, dine, Homocodeine or other trade name, its Companion of the Most Honourable Order of the Bath, salts, and any preparation, admixture, extract Lieutenant-General on the Retired List of the Australian or other substance containing not less than one Military Forces, Governor of the State of New South per centum of B-4-Morpholinylethylmorphine; Wales and its Dependencies in the Commonwealth of Thebaine, its salts, and any preparation, admixture, Australia, with the advice of the Executive Council, extract or other substance containing not less do, by this my Proclamation, declare that Part VI of than one-fifth per centum of Thebaine; the Police Offences (Amendment) Act, 1908, as amended, Meprodine (8 -l-methyl-3-ethyl-4-phenyl-4-pro- shall apply to:- pionoxypiperidine),its salts, and any preparation, admixture, extract or other substance containing not less than one-fifth per centum of Meprodine; Morphine-N-oxide, known as Genomorphine, and any in the same manner as it applies to the drugs men• preparation, admixture, extract or other sub• tioned in paragraph (a) of subsection (2) of section 18 stance containing not less than one-fifth per cen• tum of Morphine-N-oxide; of the said Act. Dihydromorphine, known as Paramorfan, or other trade name, its salts and any preparation, ad• mixture, extract or other substance containing not less than one-fifth per centum of Dihydro• morphine; Dihydromorphinone, known as Hydromorphone, Dilaudide, or other trade name, its salts, and any preparation, admixture, extract or other Signed and sealed at Sydney, this seventh day of substance containing not less than one-fifth per July, one thousand nine hundred and fifty-four centum of Dihydromorphinone; Dihydrodesoxymorphine, known as Desomorphine, Permonid, or other trade name, its salts, and By His Excellency's Command, any preparation, admixture, extract or other substance containing not less than one-fifth per centum of Dihydrodesoxymorphine; C. A. KELLY. Dihydrocodeine, known as Hydrocodin, Paracodine, or other trade name, its salts, and any prepara• tion, admixture, extract or other substance con• GOD SAVE THE QUEEN: 2 E/NL. 1955/53 Coca leaves. Diacetylmorphine, its salts, and preparations of or [Extract from Commonwealth of Australia Gazette, containing diacetylmorphine or its salts. No. 33, dated 28th May, 1953.] Dihydrocodeine (Paracodine) and its salts. Dihydrocodeinone, its esters, its salts, the salts of its AUSTRALIAN CAPITAL TERRITORY. esters, and preparations of dihydrocodeinone or of those esters or salts. Poisons and Dangerous Drugs Ordinance 1933-1938. Dihydrodesoxymorphine, its esters, its salts, the salts of its esters, and preparations of dihydrodesoxy- Notice Declaring Certain Drugs, Chemicals and Com• morphine or of those esters or salts. pounds to be Narcotic Drugs Dihydrohydroxycodeinone, its esters, its salts, the salts of its esters, and preparations of dihydro• Whereas by section twelve oi Hhe Poisons and hydroxycodeinone or of those esters or salts. Dangerous Drugs Ordinance 1933-1938 it is provided Dihydromorphine, its esters, its salts, the salts of its (inter alia) that the Minister of State for Health may, esters, and preparations of dihydromorphine or of by notice in the Gazette, declare what drugs, chemicals those esters or salts. or compounds are, for the purposes of the Ordinance, Dihydromorphinone, its esters, its salts, the salts of narcotic drugs
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20050181041A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0181041 A1 Goldman (43) Pub. Date: Aug. 18, 2005 (54) METHOD OF PREPARATION OF MIXED Related US. Application Data PHASE CO-CRYSTALS WITH ACTIVE AGENTS (60) Provisional application No. 60/528,232, ?led on Dec. 9, 2003. Provisional application No. 60/559,862, ?led (75) Inventor: David Goldman, Portland, CT (US) on Apr. 6, 2004. Correspondence Address: Publication Classi?cation LEYDIG VOIT & MAYER, LTD (51) Int. Cl.7 ....................... .. A61K 31/56; A61K 38/00; TWO PRUDENTIAL PLAZA, SUITE 4900 A61K 9/64 180 NORTH STETSON AVENUE (52) US. Cl. ............................ .. 424/456; 514/179; 514/2; CHICAGO, IL 60601-6780 (US) 514/221 (73) Assignee: MedCrystalForms, LLC, Hunt Valley, (57) ABSTRACT MD This invention pertains to a method of preparing mixed phase co-crystals of active agents With one or more materials (21) Appl. No.: 11/008,034 that alloWs the modi?cation of the active agent to a neW physical/crystal form With unique properties useful for the delivery of the active agent, as Well as compositions com (22) Filed: Dec. 9, 2004 prising the mixed phase co-crystals. Patent Application Publication Aug. 18, 2005 Sheet 1 0f 8 US 2005/0181041 A1 FIG. 1a 214.70°C z.m."m.n... 206.98°C n..0ao 142 OJ/g as:20m=3: -0.8 -1.0 40 90 1:10 2110 Temperture (°C) FIG. 1b 0.01 as:22“.Km: 217 095 24221.4 39Jmum/Q -0.8 35 155 255 255 Temperture (°C) Patent Application Publication Aug.
    [Show full text]
  • Measures and CDS for Safer Opioid Prescribing: a Literature Review
    Measures and CDS for Safer Opioid Prescribing: A Literature Review Measures and CDS for Safer Opioid Prescribing: A Literature Review Executive Summary The U.S. opioid epidemic continues to pose significant challenges for patients, families, clinicians, and public health policy. Opioids are responsible for an estimated 315,000 deaths (from 1999 to 2016) and have caused 115 deaths per day.1 In 2017, the U.S. Department of Health and Human Services declared the opioid epidemic a public health crisis.2 The total economic burden of opioid abuse in the United States has been estimated to be $78.5 billion per year.3 Although providing care for chronic opioid users is important, equally vital are efforts to prevent so-called opioid-naïve patients (patients with no history of opioid use) from developing regular opioid use, misuse, or abuse. However, much remains unclear regarding what role clinician prescribing habits play and what duration or dose of opioids may safely be prescribed without promoting long-term use.4,5 In 2013, ECRI Institute convened the Partnership for Health IT Patient Safety, and its component, single-topic-focused workgroups followed. For this subject, the Electronic Health Record Association (EHRA): Measures and Clinical Decision Support (CDS) for Safer Opioid Prescribing workgroup included members from the Healthcare Information and Management Systems Society (HIMSS) EHRA and the Partnership team. The project was oriented towards exploring methods to enable a synergistic cycle of performance measurement and identifying electronic health record (EHR)/health information technology (IT)–enabled approaches to support healthcare organizations’ ability to assess and measure opioid prescribing.
    [Show full text]
  • Texas Controlled Substances Act
    HEALTH AND SAFETY CODE TITLE 6. FOOD, DRUGS, ALCOHOL, AND HAZARDOUS SUBSTANCES SUBTITLE C. SUBSTANCE ABUSE REGULATION AND CRIMES CHAPTER 481. TEXAS CONTROLLED SUBSTANCES ACT SUBCHAPTER A. GENERAL PROVISIONS Sec.A481.001.AASHORT TITLE. This chapter may be cited as the Texas Controlled Substances Act. Acts 1989, 71st Leg., ch. 678, Sec. 1, eff. Sept. 1, 1989. Sec.A481.002.AADEFINITIONS. In this chapter: (1)AA"Administer" means to directly apply a controlled substance by injection, inhalation, ingestion, or other means to the body of a patient or research subject by: (A)AAa practitioner or an agent of the practitioner in the presence of the practitioner; or (B)AAthe patient or research subject at the direction and in the presence of a practitioner. (2)AA"Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. The term does not include a common or contract carrier, public warehouseman, or employee of a carrier or warehouseman acting in the usual and lawful course of employment. (3)AA"Commissioner" means the commissioner of state health services or the commissioner 's designee. (4)AA"Controlled premises" means: (A)AAa place where original or other records or documents required under this chapter are kept or are required to be kept; or (B)AAa place, including a factory, warehouse, other establishment, or conveyance, where a person registered under this chapter may lawfully hold, manufacture, distribute, dispense, administer, possess, or otherwise dispose of a controlled substance or other item governed by the federal Controlled Substances Act (21 U.S.C.
    [Show full text]
  • List of Narcotic Substances Circulation of Which Is Restricted in Uzbekistan
    List of narcotic substances circulation of which is restricted in Uzbekistan 1. 2C-B(4-bromo-2,5-dimethoxyphenethylamine) 2. 3-methylfentanyl 3. 3-methylthiofentanyl 4. 3-Monoacetylmorphine 5. 4-methylaminorex 6. 6- Monoacetylmorphine 7. Acetorphine 8. Acetyl Dihydrocodeine 9. Acetyl-alfametilfentanil 10. Acetylated opium 11. Acetylcodeine 12. Acetylmethadol 13. Alfametadol 14. Alfatsetilmetadol 15. all fungi that contain Psilocine and Psilocybine 16. Allylprodine 17. Alpha Methylfentanyl 18. Alpha Metiltiofentanil 19. Alphaprodine 20. Anileridin 21. Benzethidine 22. Benzylmorphine 23. Betacetylmethadol 24. Betahydroxyfentanyl 25. Betameprodine 26. Betamethadol 27. Betaprodine 28. Bezitramide 29. Cannabis oil (hashish oil) 30. Cannabis, marihuana 31. Cathine ((+)-norpseudoephedrine) 32. Cathinone (l-alpha-aminopropiofenon) 33. Clonitazene 34. Cocaine 35. Codoxime 36. d- Methadone 37. DB [L-(3,4 - methylenedioxyphenyl) -2 butanamine] 38. Desmethylprodine; MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 39. Desomorphine 40. DET (N,N-diethyltryptamine) 41. Dexamphetamine 42. Diampromide 43. Diethyl phosphate 44. Diethylthiambutene 45. Dihydromorphine 46. Dimenoxadol 47. Dimepheptanol 48. Dimethylthiambutene 49. Dioxaphetyl butyrate 50. Diphenoxine 51. Dipipanone 52. DMA (2,5-dimethoxyamphetamine) 53. DMGP (dimetilgeptilpiran) 54. DMT (dimethyltryptamine) 55. DOB (d, L-2,5-dimethoxy-4-bromo-amphetamine) 56. DOC (d, L-2,5-dimethoxy-4-chloro-amphetamine) 57. DOET (2,5-dimethoxy-4-ethylamphetamine) 58. Drotebanol 59. Ecgonine 60. Ephedrone 61. Ethylmethylthiambutene 62. Eticyclidine 63. Etonitazene 64. Etorphine 65. Etoxeridine 66. Etryptamine 67. Furethidine 68. Hashish (Anasha, cannabis resin) 69. Heroin (Diacetylmorphine) 70. Hydrocodone 71. Hydrocodone phosphate 72. Hydromorphinol 73. Hydromorphone 74. Isomethadone 75. Ketobemidone 76. Khat 77. L- Methadone 78. Levomethorphan 79. Levomoramide 80. Levophenacylmorphan 81. Levorphanol 82. Lysergic acid and its preparations, that include d-Lysergide (LSD, LSD-25) 83.
    [Show full text]
  • Schedules of Controlled Substances (.Pdf)
    PURSUANT TO THE TEXAS CONTROLLED SUBSTANCES ACT, HEALTH AND SAFETY CODE, CHAPTER 481, THESE SCHEDULES SUPERCEDE PREVIOUS SCHEDULES AND CONTAIN THE MOST CURRENT VERSION OF THE SCHEDULES OF ALL CONTROLLED SUBSTANCES FROM THE PREVIOUS SCHEDULES AND MODIFICATIONS. This annual publication of the Texas Schedules of Controlled Substances was signed by John Hellerstedt, M.D., Commissioner of Health, and will take effect 21 days following publication of this notice in the Texas Register. Changes to the schedules are designated by an asterisk (*). Additional information can be obtained by contacting the Department of State Health Services, Drugs and Medical Devices Unit, P.O. Box 149347, Austin, Texas 78714-9347. The telephone number is (512) 834-6755 and the website address is http://www.dshs.texas.gov/dmd. SCHEDULES Nomenclature: Controlled substances listed in these schedules are included by whatever official, common, usual, chemical, or trade name they may be designated. SCHEDULE I Schedule I consists of: -Schedule I opiates The following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, if the existence of these isomers, esters, ethers, and salts are possible within the specific chemical designation: (1) Acetyl-α-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) (Other name:
    [Show full text]
  • Thesis, Stereochemistry and Structure-Activity Relationship of Opioid Ligands Related to 4-Aryl-1-Methylpiperidines and Phencyclidine
    University of Bath PHD On the investigation of the synthesis, stereochemistry and structure-activity relationship of opioid ligands related to 4-aryl-1-methylpiperidines and phencyclidine Al-Deeb, Omar A. A. Award date: 1989 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 07. Oct. 2021 IN THE NAME OF. ALLAH THE MERCIFUL THE COMPASSIONATE ON THE INVESTIGATION OF THE SYNTHESIS, STEREOCHEMISTRY AND STRUCTURE-ACTIVITY RELATIONSHIP OF OPIOID LIGANDS RELATED TO 4-ARYL-l-METHYLPIPERIDINES AND PHENCYCLIDINE Thesis Submitted by OMAR A.A. AL-DEEB, B.SC., M.So., for the degree of Doctor of Philosophy of the University of Bath 1989 This research has been carried out in the School of Pharmacy and Pharmacology under the supervision of Dr.
    [Show full text]
  • Thesis Rests with the Author
    University of Bath PHD Stereochemical studies of narcotic analgesics related to pethidine and fentanyl. Ogungbamila, Francis Omoseyin Award date: 1982 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 07. Oct. 2021 STEREOCHEMICAL STUDIES OF NARCOTIC ANALGESICS RELATED TO PETHIDINE AND FENTANYL. Submitted by FRANCIS OMOSEYIN OGUNGBAMILA for the degree of Doctor of Philosophy of the University of Bath, 1982. This research has been carried out in the School of Pharmacy and Pharmacology of the University of Bath, under the supervision of Dr. A.F. Casy, D.Sc., Ph.D., F.P.S., C.Chem., F .R.S.C. COPYRIGHT. Attention is drawn to the fact that copyright of this thesis rests with the author.
    [Show full text]
  • ATP, 489 Absolute Configuration Benzomotphans, 204 Levotphanol
    Index AIDA, 495 Affinity labeling, analogs of (Cont.) cAMP, 409, 489 motphine,448 ATP, 409, 489 naltrexone, 449 [3H] ATP, 489 norlevotphanol,449 Absolute configuration normetazocine, 181 benzomotphans, 204 norpethidine, 232 levotphanol, 115 oripavine, 453 methadone and analogs, 316 oxymotphone, 449 motphine, 86 K-Agonists, 179,405,434 phenoperidine, 234 Aid in Interactive Drug Analysis, 495 piperazine derivatives, 399 [L-Ala2] dermotphin, 363 prodines and analogs, 272 [D-Ala, D-Leu] enkephalin (DADL), 68, 344 sinomenine, 28, 115 [D-Ala2 , Bugs] enkephalinamide, 347, 447 viminol, 400 [D-Ala2, Met'] enkephalinamide, 337, 346, Ac 61-91,360 371,489 Acetylcholine, 5, 407 [D-Ala2]leu-enkephalin, 344, 346, 348 Acetylcholine analogs, 186, 191 [D-Ala2] met-enkephalin, 348 l-Acetylcodeine, 32 [D-Ala2] enkephalins, 347 Acetylmethadols (a and (3) Alfentanil, 296 maintenance of addicts by a-isomer, 304, 309 (±)-I1(3-Alkylbenzomotphans, 167, 170 metabolism, 309 11(3-Alkylbenzomotphans, 204 N-allyl and N-CPM analogs, 310, 431 7-Alkylisomotphinans, 146 stereochemistry, 323 N-Alkylnorketobemidones, 431 synthesis, 309 N-Alkylnorpethidines, 233 X-ray crystallography, 327 N-Allylnormetazocine, 420 6-Acetylmotphine, receptor binding, 27 N-Allylnormotphine, 405 Acetylnormethadol, 323 N-Allylnorpethidine, 233 8(3-Acyldihydrocodeinones, 52 3-Allylprodines (a and (3), 256 14-Acyl-4,5-epoxymotphinans, 58 'H-NMR and stereochemistry, 256 7-Acylhydromotphones, 128 X-ray crystallography, 256 Addiction, 4 N-Allylnormetazocine, 420 Adenylate cyclase, 6, 409, 413, 424,
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0317530 A1 Sandhu Et Al
    US 20160317530A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0317530 A1 Sandhu et al. (43) Pub. Date: Nov. 3, 2016 (54) ABUSE-RESISTANT DRUG FORMULATIONS Publication Classification (71) Applicant: KASHIV PHARMA, LLC, (51) Int. Cl. Bridgewater, NJ (US) A63L/485 (2006.01) A63L/35 (2006.01) (72) Inventors: Harpreet Kaur Sandhu, West Orange, A6II 47/22 (2006.01) NJ (US); Siva Ram Kiran Vaka, A6II 47/8 (2006.01) Piscataway, NJ (US); Ashish Chatterji, A6II 47/10 (2006.01) East Brunswick, NJ (US); Dipen Desai, A6II 47/4 (2006.01) Whippany, NJ (US); Wantanee A6II 47/02 (2006.01) Phuapradit, Montville, NJ (US); A6II 47/44 (2006.01) Navnit H. Shah, Clifton, NJ (US) A6II 3/167 (2006.01) A6II 47/20 (2006.01) (52) U.S. Cl. (73) Assignee: Kashiv Pharma, LLC, Bridgewater, NJ CPC ........... A61K 31/485 (2013.01); A61K 3 1/167 (US) (2013.01); A61K 31/135 (2013.01); A61 K 47/22 (2013.01); A61K 47/20 (2013.01); A61 K (21) Appl. No.: 15/108,157 47/10 (2013.01); A61K 47/14 (2013.01); A61 K 47/02 (2013.01); A61K 47/44 (2013.01); A61 K (22) PCT Fed: Dec. 31, 2014 47/18 (2013.01) (86) PCT No.: PCT/US2O14/072968 (57) ABSTRACT Disclosed are abuse resistant oral pharmaceutical composi S 371 (c)(1), tions that reduce the likelihood of improper administration (2) Date: Jun. 24, 2016 of drugs that are susceptible to abuse. The oral pharmaceu tical formulations contain abuse deterrent agents that cause discomfort to the user when administered in an improper Related U.S.
    [Show full text]
  • Chapter 152 Minnesota Statutes 1974
    MINNESOTA STATUTES 1974 2111 PROHIBITED DRUGS 152.01 CHAPTER 152 PROHIBITED DRUGS Sec. Sec. 152.01 Definitions 152.12 Doctors may prescribe 152.02 Schedules of controlled substances; admin­ 152.13 Duties of state board of pharmacy istration of chapter 152.15 Violations; penalties 152.09 Prohibited acts 152.18 Discharge and dismissal 152.10 Sales, persons eligible 152.19 Forfeitures 152.101 Manufacturers, records 152.20 Penalties under other laws 152.11 Written or oral prescriptions, requisites 152.01 DEFINITIONS. Subdivision 1. Words, terms, and phrases. Unless the language or context clearly indicates that a different meaning is intended, the fol­ lowing words, terms, and phrases, for the purposes of this chapter, shall be given the meanings subjoined to them. Subd. 2. Drug. The term "drug" includes all medicines and preparations recognized in the United States pharmacopoeia or national formulary and any substance or mixture of substances intended to be used for the cure, mitigation, or prevention of disease of either man or other animals. Subd. 3. M.S. 1967 [Repealed, 1969 c 933 s 22] Subd. 3. Administer. "Administer" means to deliver by, or pursuant to the lawful order of a practitioner a single dose of a controlled substance to a patient or research subject by injection, inhalation, ingestion, or by any other immediate means. Subd. 4. M.S. 1967 [Repealed, 1969 c 933 s 22] Subd. 4. Controlled substance. "Controlled substance" means a drug, sub­ stance, or immediate precursor in Schedules I through V of section 152.02. The term shall not include distilled spirits, wine, malt beverages, intoxicating liquors or tobacco.
    [Show full text]
  • Chapter 152 Prohibited Drugs
    MINNESOTA STATUTES 1984 3593 PROHIBITED DRUGS 152.01 CHAPTER 152 PROHIBITED DRUGS 152.01 Definitions. 152.097 Simulated controlled substances. 152.02 Schedules of controlled substances; ad­ 152.10 Sales, persons eligible. ministration of chapter. 152.101 Manufacturers, records. 152.09 Prohibited acts. 152.11 Written or oral prescriptions, requisites. 152.092 Possession of drug paraphernalia pro­ 152.12 Doctors may prescribe. hibited. 152.13 Duties of state board of pharmacy. 152.093 Manufacture or delivery of drug para­ 152.15 Violations; penalties. phernalia prohibited. 152.151 Report to legislature. 152.094 Delivery of drug paraphernalia to a mi­ 152.18 Discharge and dismissal. nor prohibited. 152.19 Forfeitures. 152.095 Advertisement of drug paraphernalia 152.20 Penalties under other laws. prohibited. 152.205 Local regulations. 152.096 Conspiracies prohibited. 152.21 THC Therapeutic Research Act. 152.01 DEFINITIONS. Subdivision 1. Words, terms, and phrases. Unless the language or context clearly indicates that a different meaning is intended, the following words, terms, and phrases, for the purposes of this chapter, shall be given the meanings subjoined to them. Subd. 2. Drug. The term "drug" includes all medicines and preparations recognized in the United States pharmacopoeia or national formulary and any substance or mixture of substances intended to be used for the cure, mitigation, or prevention of disease of either man or other animals. Subd. 3. MS 1967 [Repealed, 1969 c 933 s 22] Subd. 3. Administer. "Administer" means to deliver by, or pursuant to the lawful order of a practitioner a single dose of a controlled substance to a patient or research subject by injection, inhalation, ingestion, or by any other immediate means.
    [Show full text]